Accessibility Menu
Arrow-Thin-Down
S&P 500
6,699.40
-0.5%
-35.95
Arrow-Thin-Down
DJI
46,590.41
-0.7%
-334.33
Arrow-Thin-Down
NASDAQ
22,740.40
-0.9%
-213.27
Arrow-Thin-Down
Bitcoin
$108,586
+0.1%
+$144.64
Arrow-Thin-Down
AAPL
$258.4
-1.7%
-$4.37
Arrow-Thin-Down
AMZN
$217.92
-1.9%
-$4.11
Arrow-Thin-Down
GOOG
$252.45
+0.4%
+$1.11
Arrow-Thin-Down
META
$733.46
+0.0%
+$0.19
Arrow-Thin-Down
MSFT
$520.63
+0.6%
+$2.97
Arrow-Thin-Down
NVDA
$180.05
-0.6%
-$1.12
Arrow-Thin-Down
TSLA
$438.89
-0.8%
-$3.72
Daily Stock GainersDaily Stock LosersMost Active Stocks

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price
$0.00
Daily Change
(-) $0.00
Day's Range
$0.00 - $0.00
Previous Close
$0.00
Open
$0.00
Beta
0
Volume
-
Average Volume
-
Sector
Health Care
Market Cap
-
Market Cap / Employee
-
52wk Range
$0.00 - $0.00
Revenue
-
Gross Margin
-
Dividend Yield
-
EPS
$0.00
CAPs Rating
-
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Accolade Company Info

Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company was founded by Thomas K. Spann, J. Michael Cline, and Sudhir Steven Singh in January 2007 and is headquartered in Seattle, WA.

News & Analysis

Featured Article

Why Shares of Accolade Fell This Week

The company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed.

James Halley  |  Oct 6, 2023
Featured Article

Why Accolade Stock Popped by Almost 7% Today

A double beat and raised guidance bring the bulls roaring back to the stock.

Eric Volkman  |  Jun 30, 2023

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services